Is a 111 Blood Sugar Level Good or Bad?

A fasting blood sugar of 111 mg/dL is not normal, but it is not yet diabetes. It falls squarely within the range known as impaired fasting glucose, which most clinicians classify as prediabetes. The standard cutoffs define normal fasting glucose as below 100 mg/dL and diabetes as 126 mg/dL or above, which places 111 in the middle of that in-between zone. That sounds like a mild concern, and in many ways it is, but the picture is more interesting and more actionable than the label “prediabetes” might suggest.

What Impaired Fasting Glucose Actually Means in Your Body

When your fasting blood sugar sits at 111 mg/dL, something specific is happening overnight and in the early morning hours. Your liver is releasing more glucose into the bloodstream than it should be, and the insulin your pancreas produces is not suppressing that release as effectively as it does in someone with a fasting level of, say, 88. Research comparing people with impaired fasting glucose to those with normal levels has shown that people in the IFG range have both hepatic (liver) and extrahepatic insulin resistance, even though their insulin and C-peptide levels are actually higher, meaning the body is working harder to maintain glucose control and not fully succeeding.¹

There is also a timing problem with insulin release. People with impaired fasting glucose tend to have blunted early-phase insulin secretion, the quick burst of insulin your pancreas fires in the first few minutes after glucose enters the bloodstream.² The late phase usually still works fine, which is why many people with IFG can handle a meal reasonably well and might even have a normal post-meal glucose reading. But the fasting number tells a different story because overnight, when the liver is steadily producing glucose and there is no meal stimulus to trigger a big insulin response, that sluggish early insulin signal lets glucose drift upward.

The Cardiovascular Connection

One of the reasons doctors pay attention to a number like 111 is that cardiovascular risk starts climbing before glucose reaches the diabetes threshold. A large study tracking fasting glucose levels and atherosclerotic cardiovascular events found that once fasting glucose exceeded 100 mg/dL, risks for cardiovascular disease, ischemic heart disease, heart attack, and blood-clot-related stroke all progressively increased.³ That is not a cliff edge at 100, but a gradient, and 111 is further along that gradient than 101.

Data from a Korean study involving a large population found that people with higher-grade impaired fasting glucose had a roughly 30% increased hazard for cardiovascular disease compared to those with normal glucose levels, while diabetes carried an 81% increase.⁴ So you are not in the diabetes risk bracket, but you are not at the baseline level either. The Rotterdam Study, which followed people from age 55 onward, found that lifetime cardiovascular risk for people with impaired fasting glucose was modestly higher than for those with normal glucose, though the gap was narrower than many people expect, roughly a few percentage points of additional lifetime risk rather than a dramatic leap.⁵

Does 111 Mean You Are Headed for Diabetes?

Not necessarily, and for many people, the answer turns out to be no. The trajectory from impaired fasting glucose to type 2 diabetes is not a one-way conveyor belt. In a study of older adults with prediabetes defined by fasting glucose, about 44% actually regressed to normal levels during follow-up, roughly a third stayed in the IFG range, and only about 8% progressed to diabetes. About 16% died of other causes before either outcome occurred.⁶ The researchers concluded that prediabetes in older adults may not be a reliable predictor of diabetes progression, a finding that challenges the common assumption that every prediabetic reading is a countdown to the disease.

That said, certain factors do push the odds in the wrong direction. Higher body fat percentage, advancing age, and higher starting fasting glucose within the IFG range are all associated with a greater chance of eventually crossing the diabetes threshold.⁷ So a 111 in someone who is lean and active carries different prognostic weight than a 111 in someone who is overweight and sedentary. The number is the same, but the story behind it is not.

Microvascular Damage Can Start Before Diabetes

One of the less well-known aspects of prediabetes is that the small-vessel complications usually associated with diabetes, such as early changes in the eyes and kidneys, can already be present at glucose levels below the diabetes cutoff.⁸ A large study comparing people diagnosed with diabetes who had a prior history of prediabetes to those who had been in the normal glucose range before diagnosis found that the prediabetes group had substantially higher odds of retinopathy (about 76% higher) and modestly higher odds of kidney damage at the time of their diabetes diagnosis.⁹ This suggests that the years spent in the prediabetic range were not benign, and that damage accumulates even when the numbers look only slightly off.

This does not mean a fasting glucose of 111 guarantees you have retinal or kidney changes. Most people at that level do not. But it is a reminder that the body does not wait for an arbitrary diagnostic line to start experiencing effects from higher-than-optimal glucose.

Could Your Reading Be Off?

Before drawing any conclusions from a single fasting glucose of 111, it is worth asking how it was measured. Home glucose meters and even some clinical analyzers introduce variability that can move a reading by 10 to 15 mg/dL in either direction. Research has shown that differences between capillary blood (from a finger stick) and venous blood (from a vein), and between meters and lab-grade instruments, can produce meaningful shifts in results, especially when the meter technology is sensitive to oxygen levels in the blood sample.¹⁰ That means a home-meter reading of 111 could reflect a true value anywhere from the high 90s to the low 120s.

This is why most guidelines call for a repeat test, ideally a venous lab draw, before formally diagnosing prediabetes. A single reading is a data point, not a diagnosis. If a lab-confirmed fasting glucose comes back at 111 on two separate occasions, the result is more reliable. Adding an HbA1c test, which reflects average blood sugar over about three months, provides another angle, though these two tests do not always agree. A study of Black South African adults found that HbA1c and fasting glucose classifications were discordant in about 16% of participants.¹¹ Factors like anemia, hemoglobin variants, and liver disease can skew HbA1c results, so your doctor might weigh the two tests differently depending on your situation.

Things That Temporarily Push Fasting Glucose Up

A 111 reading may not reflect your usual metabolic state. Several common situations can elevate fasting glucose by enough to push a borderline number over the 100 mark or inflate it above where it normally sits. Poor sleep is one of the most underrecognized. Even a couple of nights of short or disrupted sleep can impair glucose tolerance through effects on cortisol and insulin sensitivity. Acute stress, whether from illness, emotional distress, or physical pain, triggers cortisol release that directly raises blood sugar. Dehydration concentrates the blood slightly and can nudge glucose upward. And some people who technically fast for the required 8 to 12 hours before a blood draw still have lingering metabolic effects from a very late or very large meal the previous night.

If your reading was taken during a stressful week, after a bad night’s sleep, or while you were fighting a cold, it is reasonable to retest under better conditions before assuming the number represents your baseline.

Medications That Can Raise Fasting Glucose

Several widely prescribed medications can nudge fasting blood sugar upward. Statins, the cholesterol-lowering drugs taken by tens of millions of people, are among the best-studied offenders. The risk of developing new-onset diabetes is higher in people taking statins, and this risk increases with dose and duration of use.¹² Not all statins appear to have the same effect. A trial comparing different statins in people who already had impaired fasting glucose found that rosuvastatin was associated with increased insulin resistance compared to pravastatin and a control group.¹³

Other common medication classes that can raise fasting glucose include corticosteroids (like prednisone), certain blood pressure medications (particularly thiazide diuretics and some beta-blockers), and some antipsychotic drugs. If you are taking any of these and your fasting glucose has crept into the 111 range, it is worth discussing with your doctor whether the medication is a contributor, though stopping a needed medication purely to lower fasting glucose by a few points is rarely the right trade-off.

What Actually Works to Bring It Down

The good news about a fasting glucose of 111 is that the prediabetic range is one of the most responsive stages to lifestyle changes. A systematic review and meta-analysis pooling results from multiple trials found that lifestyle modification programs resulted in about 39% of participants returning to normal glucose levels, compared to 21% of those who received standard care.¹⁴ In practical terms, for every six people who made structured lifestyle changes, one additional person normalized their glucose who would not have otherwise.

For women with isolated impaired fasting glucose specifically, a randomized trial found that a structured lifestyle program achieved prediabetes remission in about 46% of participants versus only 6% of controls. That translated to needing to treat fewer than three people for one to achieve remission.¹⁵ The changes were not dramatic in isolation: average weight loss was about 4 kg (around 8 pounds), waist circumference dropped modestly, and fasting glucose declined by about 5 mg/dL. But collectively, these shifts were enough to tip the metabolic balance back toward normal.

The core interventions in most successful lifestyle programs are familiar: moderate weight loss (around 5 to 7% of body weight), at least 150 minutes of moderate-intensity physical activity per week, and dietary changes that reduce refined carbohydrates and increase fiber. These do not need to be exotic or extreme. Walking counts. Replacing sugary drinks with water counts. Eating more vegetables and fewer processed snacks counts. The consistency matters far more than the intensity.

For people who struggle with lifestyle changes alone, or who have additional risk factors, metformin is sometimes prescribed. A meta-analysis found that metformin reduced the risk of progressing from prediabetes to diabetes by about 35%, and the benefit was strongest specifically in people with impaired fasting glucose, where risk was reduced by about 62%.¹⁶ Lifestyle programs and metformin are not mutually exclusive; they can work together.

Age Changes the Equation

If you are over 65 and see a fasting glucose of 111, the calculus is somewhat different than for a 40-year-old. As mentioned earlier, older adults with prediabetes are more likely to regress to normal or stay stable than to progress to diabetes.⁶ Fasting glucose also tends to drift upward with age even in healthy people. Continuous glucose monitoring data from healthy, non-diabetic participants shows that average 24-hour glucose runs around 99 mg/dL across most age groups but rises to about 104 mg/dL in people 60 and older.¹⁷

There is another wrinkle for older adults with established diabetes: research in older Chinese patients found that the relationship between fasting glucose and mortality follows a J-shaped curve, meaning that very low fasting glucose is also associated with higher risk, not just very high glucose. The lowest-risk range for all-cause mortality was roughly 99 to 135 mg/dL (5.50 to 7.50 mmol/L).¹⁸ That study was in people who already had diabetes, so the numbers do not directly apply to someone with a fasting glucose of 111 and no diabetes diagnosis. But it illustrates an important principle: aggressively driving glucose down is not always beneficial, especially in older adults where hypoglycemia carries its own serious risks.

The Global Threshold Debate

The cutoff of 100 mg/dL that places a reading of 111 in the “impaired” zone is not universally agreed upon. The American Diabetes Association lowered this threshold from 110 to 100 mg/dL in 2003, but the World Health Organization kept its IFG threshold at 110 mg/dL. Under WHO criteria, a fasting glucose of 111 would barely register as impaired, while under ADA criteria, it is firmly in the prediabetic range. This difference is not trivial. A study comparing the two classification systems found that about 68% of people classified as having impaired fasting glucose under the ADA criteria would have been called normal under the older WHO criteria.¹⁹

This means that if you are reading about prediabetes in a medical system that uses WHO criteria, a reading of 111 might be considered only minimally abnormal. In a system that uses ADA criteria, it is more clearly flagged. Neither system is objectively “right.” The ADA lowered the cutoff to capture more people at risk earlier, on the theory that earlier intervention is better. Critics argue this reclassified millions of people as prediabetic who were unlikely to ever develop diabetes, creating unnecessary worry. Where 111 falls in terms of clinical concern depends partly on which medical tradition your doctor follows.

The Mental Health Angle

Getting a fasting glucose result of 111 and being told you have prediabetes can trigger real anxiety, and that emotional response can itself become part of the problem. Research has found that the combination of prediabetes and elevated depressive symptoms is associated with a substantially higher risk of progressing to diabetes than either factor alone, and the interaction appears to be more than additive.²⁰ High anxiety symptoms showed a similar pattern, though the statistical evidence for a synergistic effect was weaker.

This is not to say that worrying about your blood sugar will give you diabetes. But chronic psychological distress affects cortisol levels, sleep quality, eating patterns, and physical activity, all of which influence glucose regulation. If a prediabetes diagnosis sends you into a spiral of worry, addressing that emotional response through stress management, therapy, or simply talking to your doctor about what the number realistically means can be a legitimate part of improving your metabolic outlook.

Diet Quality Beyond Calories

Most discussions of prediabetes reversal focus on weight loss and exercise, but specific dietary components may play a role beyond their calorie content. One cohort study tracking people with impaired fasting glucose found that high dietary intake of nitrates and nitrites, found in processed meats and some preserved foods, was associated with a meaningfully higher risk of progressing to type 2 diabetes. Those with the highest nitrite intake had roughly double the risk of progression compared to the lowest intake group.²¹ This is a single cohort study, not definitive proof, but it aligns with broader evidence linking processed meat consumption to diabetes risk and suggests that what you eat may matter for reasons beyond its effect on your weight.

Vegetable-derived nitrates, which come packaged with fiber and other protective compounds, are chemically similar but appear to behave differently in the body. The study was specifically looking at total dietary nitrate and nitrite intake, and the hazard was more pronounced with nitrite, which is heavily concentrated in cured and processed meats. If you are looking for a simple dietary change with potential metabolic benefits beyond calorie control, cutting back on bacon, deli meats, and hot dogs is a reasonable place to start.

When Lifestyle Intervention Pays Off Economically

For anyone weighing whether a prediabetes intervention program is “worth it,” cost-effectiveness research provides some perspective. A modeling study found that compared to no prevention efforts, lifestyle intervention averted about 9.5% of diabetes cases and actually saved money over time by reducing the burden of downstream complications like cardiovascular disease, kidney damage, and vision loss. The intervention produced an additional half a quality-adjusted life year while saving about $700 per person.²² In other words, the intervention was not just cost-effective; it was cost-saving. Programs modeled on the Diabetes Prevention Program, which many insurers and community health organizations now offer, are among the rare preventive interventions that pay for themselves.